Hi Vikasgoyal,
Most doctors treat low risk MDS with supportive therapy.
I have not been able to find any studies about Dacogen for low risk MDS patients but studies of Vidaza show that low risk patients can have decreased overall survival after treatment with Vidaza.
https://ash.confex.com/ash/2012/webp...aper52209.html
As far as I understand your father is doing OK with the treatment he is getting now. His HGB is maybe too low so he should have more frequent transfusions. Is he not getting any iron chelation drug?
Kind regards
Birgitta-A